These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Experimental and clinical pharmacology of oral antidiabetics]. Cuomo V; Marino A Clin Ter; 1972 Sep; 62(6):505-52. PubMed ID: 4674507 [No Abstract] [Full Text] [Related]
8. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents]. Pernet A; Bäbler M; Ganz K Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361 [No Abstract] [Full Text] [Related]
12. Oral hypoglycemic agents: the pharmacological basis of their clinical use. Davidoff F R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221 [No Abstract] [Full Text] [Related]
13. [Use of oral hypoglycemic agents in diabetic children]. Otto-Buczkowska E Pol Tyg Lek; 1973; 28(24):904-7. PubMed ID: 4724902 [No Abstract] [Full Text] [Related]
14. [Long term efficacy and tolerance of antidiabetic treatments. New data]. Mirouze J Nouv Presse Med; 1974 Jun; 3(24):1551-4. PubMed ID: 4211493 [No Abstract] [Full Text] [Related]
15. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer. Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427 [No Abstract] [Full Text] [Related]
17. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus. Fövényi J Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874 [No Abstract] [Full Text] [Related]
19. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]